A detailed history of P2 Capital Partners, LLC transactions in Liva Nova PLC stock. As of the latest transaction made, P2 Capital Partners, LLC holds 950,000 shares of LIVN stock, worth $49.9 Million. This represents 5.71% of its overall portfolio holdings.

Number of Shares
950,000
Previous 800,000 18.75%
Holding current value
$49.9 Million
Previous $44.8 Million 16.37%
% of portfolio
5.71%
Previous 5.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $7.76 Million - $9.62 Million
150,000 Added 18.75%
950,000 $52.1 Million
Q1 2024

May 15, 2024

SELL
$48.6 - $57.12 $2.43 Million - $2.86 Million
-50,000 Reduced 5.88%
800,000 $44.8 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $4.84 Million - $6.65 Million
-100,000 Reduced 10.53%
850,000 $43.2 Million
Q2 2022

Aug 15, 2022

BUY
$57.25 - $86.63 $17.1 Million - $25.9 Million
298,417 Added 45.8%
950,000 $59.3 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $50 Million - $60.4 Million
651,583 New
651,583 $57 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.81B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track P2 Capital Partners, LLC Portfolio

Follow P2 Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of P2 Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on P2 Capital Partners, LLC with notifications on news.